Avanos Medical (AVNS) Operating Leases (2019 - 2026)

Avanos Medical has disclosed Operating Leases across 8 years of filings, most recently posting $29.8 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $29.8 million, up 29.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.8 million (up 29.0% YoY), and the FY2025 annual result was $20.4 million, down 42.54% from the prior year.
• Operating Leases came in at $29.8 million for Q1 2026 at Avanos Medical, up from $20.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $44.5 million in Q4 2022 to a low of $20.4 million in Q4 2025.
• The 5-year median for Operating Leases is $29.5 million (2023), against an average of $30.3 million.
• Across the five-year window, Operating Leases plunged 42.54% in 2025 and rose 29.0% in 2026, its largest moves.
• Avanos Medical's Operating Leases stood at $44.5 million in 2022, then slumped by 36.4% to $28.3 million in 2023, then rose by 25.44% to $35.5 million in 2024, then slumped by 42.54% to $20.4 million in 2025, then jumped by 46.08% to $29.8 million in 2026.
• The last three Operating Leases figures came in at $29.8 million (Q1 2026), $20.4 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.